1. July 29, 2022

    Geographical allocation changes boost heart and lung transplant program at Mayo Clinic in Minnesota

    An expanded geographical reach with the 2017 to 2018 U.S. heart and lung transplant allocation changes has prompted significant program expansion at Mayo Clinic's Minnesota campus.

  2. July 01, 2022

    Women with cardiovascular disease in pregnancy receive multidisciplinary care

    Women with all types of cardiovascular disease receive comprehensive care during pregnancy, from preconception counseling to postpartum follow-up and risk factor assessment.

  3. March 31, 2022

    Innovative endovascular band placement may eliminate or delay surgery for infants with congenital heart disease

    Endovascular band placement regulates blood flow to the lungs, avoiding or delaying surgery for infants with congenital heart disease.

  4. March 31, 2022

    New physician guidelines to identify patients at risk of sudden cardiac death

    Updated guidelines help primary care physicians and pediatric cardiologists identify and treat patients at risk of sudden cardiac death.

  5. March 31, 2022

    Surgery for hypertrophic cardiomyopathy benefits pediatric patients

    Surgical myectomy produces greater late survival and a better quality of life than the expected survival of pediatric patients with obstruction treated with medical therapy alone.

  6. March 31, 2022

    New protocols expand donor pool for highly sensitized pediatric patients receiving heart transplants

    Use of induction immunosuppression and removal of antibodies that could affect donor hearts allow use of hearts that historically may have been contraindicated.

  7. March 31, 2022

    Expertise in the nuances of diagnosis, management and surgery for vascular rings

    Specialists developed an algorithm to evaluate patient risk, best age for surgery and when birth should occur at hospitals equipped for pediatric heart surgery to correct vascular rings.

  8. March 28, 2022

    Lack of sleep increases unhealthy abdominal fat

    ROCHESTER, Minn. — New research from Mayo Clinic shows that lack of sufficient sleep combined with free access to food increases calorie consumption and consequently fat accumulation, especially unhealthy fat inside the be[...]

  9. Jan. 18, 2022

    Direct oral anticoagulants significantly decrease recurrent venous thrombosis for adult cancer patients, Mayo Clinic study finds

    ROCHESTER, Minn. — Direct oral anticoagulants should be considered the standard of care to treat adult patients with cancer-associated thrombosis, according to a new, ongoing study by Mayo Clinic researchers. Thrombosis is[...]

  10. Jan. 14, 2022

    Artificial intelligence can identify patients at risk of atrial fibrillation and heart failure in Graves' disease

    Artificial intelligence (AI) helps identify patients with Graves' disease who are at increased risk of developing atrial fibrillation (AF) and heart failure and who may benefit from closer surveillance.

  11. Jan. 05, 2022

    Cardiovascular risks may be worse for thinking, memory skills in middle-aged women

    ROCHESTER, Minn. — A Mayo Clinic study shows heart conditions such as coronary artery disease and cardiovascular risk factors such as diabetes and high cholesterol have stronger association with decline in memory and think[...]

  12. Dec. 07, 2021

    Sex and race disparities found in management of patients with hypertrophic cardiomyopathy in the hospital

    ROCHESTER, Minn. — In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy (HCM) has increased. However, a new Mayo Clinic study finds that ICDs ar[...]

  13. Sept. 24, 2021

    Aortic stenosis severity underestimated when mean gradient is obtained during atrial fibrillation

    Research on the significance of high transvalvular gradients in atrial fibrillation low-gradient aortic stenosis indicates aortic stenosis severity is underestimated when the mean gradient is obtained during atrial fibr[...]

  14. Aug. 27, 2021

    Mayo Clinic in Florida: First hospital in the world to use a new heart pump as bridge to transplant

    Mayo Clinic in Florida is the only hospital internationally using the new Impella 5.5 heart pump as a bridge to transplant. The pump offers numerous advantages over the left ventricular assist device.

  15. Aug. 17, 2021

    Order is everything: New procedure for heart-liver transplant averts rejection risk

    A Mayo Clinic study published in Journal of the American College of Cardiology shows transplanting the liver first in a heart-liver transplant significantly decreases rejection rates for highly sensitized patients.

  16. Aug. 11, 2021

    Organ perfusion systems a boon to heart and lung transplants

    Transplant specialists at Mayo Clinic in Florida use organ perfusion systems for some heart and lung transplants, resulting in multiple advantages for recipients — including saving lives.

  17. July 27, 2021

    20-year Mayo Clinic study suggests return to play is manageable for athletes with most genetic heart diseases

    ROCHESTER, Minn. — Receiving the diagnosis of a genetic heart disease such as long QT syndrome, which can cause sudden cardiac death, has long been a game-ender for young athletes. But a 20-year study at Mayo Clinic follow[...]

  18. July 09, 2021

    Beyond Stem Cells, Regenerative Medicine Finds Exosomes

    Researchers studying the difference between responders and nonresponders to stem cell therapy found a crucial difference in the types of exosomes released by highly regenerative stem cells.

  19. July 01, 2021

    Mayo Clinic first to use next generation 4D ICE imaging to help patients with structural heart disease

    Mayo Clinic recently became the first to use a next-generation 4D intracardiac echo (ICE) device in patients to guide heart procedures such as left atrial appendage closure, mitral valve repair and treatment of tricuspid v[...]

  20. June 03, 2021

    Mayo Clinic study provides clarity on use of anticoagulants in gastrointestinal cancers

    ROCHESTER, Minn. -- A study by Mayo Clinic researchers provides some clarity in the use of direct oral anticoagulants (DOAC), such as apixaban and rivaroxaban, to treat acute venous thromboembolism (VTE) in patients w[...]

  21. May 06, 2021

    Trial demonstrates early AI-guided detection of heart disease in routine practice

    ROCHESTER, Minn. ? Heart disease can take a number of forms, but some types of heart disease, such as asymptomatic low ejection fraction, can be hard to recognize, especially in the early stages when treatment would be mos[...]

  22. April 03, 2021

    Transforming cardiovascular treatment for the transgender population

    The Women's Heart Clinic and Transgender and Intersex Specialty Care Clinic at Mayo Clinic partner to provide assessment of the cardiovascular risk of gender-affirming surgery.

  23. April 03, 2021

    Pediatric tracheal surgery: A multidisciplinary team approach to management

    At Mayo Clinic, the current techniques of simultaneous tracheal and cardiac repairs have yielded excellent early and late results for pediatric patients requiring tracheal surgery.

  24. March 17, 2021

    Genetic testing proves beneficial in prescribing effective blood thinners

    ROCHESTER, Minn. -- Pharmacogenomics is a valuable tool for health care providers to help prescribe the right drug for the right patient to enhance efficacy and avoid side effects. A new research paper funded in part by th[...]

  25. Feb. 25, 2021

    Heart disease in African American women: The health disparities and how to overcome them

    Heart disease is the No. 1 cause of death in women in the U.S. And African American women have an even higher risk of dying from heart disease, at a younger age, that white women, according to the National Heart, Lung, and[...]

  26. Dec. 08, 2020

    Advanced heart failure complexities and when to refer for specialty care

    Daniel S. Yip, M.D., responds to questions about challenges in pinpointing a patient's heart failure status and when cardiologists might consider referral for advanced heart failure care.

  27. Dec. 01, 2020

    Statins can save lives, are they being used?

    ROCHESTER, Minn. ? People who have coronary artery disease, stroke or peripheral artery disease often are prescribed a statin, a cholesterol-lowering drug that reduces the risk of heart attack or stroke. In a recent public[...]

  28. Nov. 26, 2020

    Drug use impacts the care required by patients with infective endocarditis

    A study of nearly 35,000 heart valve surgeries indicates that in some regions of the U.S., drug use-associated infective endocarditis now constitutes a majority of infective endocarditis valve surgeries.

  29. Nov. 26, 2020

    TAILOR-PCI narrowly misses primary goal but indicates intriguing trends

    The TAILOR-PCI trial explores whether anti-platelet therapy guided by CYP2C19 genetic metabolizer status could reduce the incidence of ischemic events after percutaneous coronary intervention.

  30. Nov. 26, 2020

    Congenital cardiac surgery: What's next?

    Mayo Clinic's congenital cardiac surgery specialists provide corrective care for many patients with congenital heart disease. These patients live with an excellent quality of life into adulthood.

  31. Nov. 20, 2020

    Blood clots in the heart are common in patients with COVID-19

    ROCHESTER, Minn. -- Researchers continue to study the effects of COVID-19 on the heart, including myocarditis -- a focused inflammation of the heart muscle. New research from Mayo Clinic suggests that myocarditis might not[...]

  32. Oct. 03, 2020

    MitraClip treatment of mitral regurgitation after cardiac transplant: Case report

    A 72-year-old male who underwent orthotopic cardiac transplantation received MitraClip placement for severe mitral regurgitation, with almost complete resolution of symptoms within weeks of implantation.

  33. Oct. 03, 2020

    Genetic testing reveals cause of mysterious deaths in Amish children

    Molecular autopsy employs genetic testing to understand the cause of sudden death and better predict risk for surviving family members.

  34. Oct. 03, 2020

    New and novel treatments for hyperlipidemia

    Clinical outcome trials study the use of human monoclonal antibodies to target biochemical pathways that impact LDL receptor availability and monoclonal antibodies to block the PCSK-9 protein.

  35. Aug. 31, 2020

    Mayo Clinic Q&A podcast: Heart muscle damage from COVID-19

    From the beginning of the COVID-19 pandemic, it was known that the disease affected the lungs. But some of the most severe damage to the body can be to the heart muscle. COVID-related myocarditis, or inflammation of the he[...]

  36. Aug. 21, 2020

    Cardio-oncology — A marriage of cardiology & oncology

    With more cancer drug options and increased treatment success, patients with cancer are surviving in record numbers. To address negative side effects of therapies on the heart and vascular function, Mayo Clinic establis[...]

  37. Feb. 01, 2020

    Modified immunosuppressive regimen improves survival in heart transplant patients

    Retrospective research shows that early conversion from a calcineurin inhibitor-based regimen to sirolimus lowers rates of cardiac allograft vasculopathy and malignancy in heart transplant recipients.

  38. Feb. 01, 2020

    Earlier intervention may improve outcomes in patients with aortic valve regurgitation

    Researchers report that patients had a higher mortality once they developed symptoms, and aortic valve surgery should be considered at an earlier stage of left ventricular enlargement.

  39. Feb. 01, 2020

    Does reduction in red meat consumption improve health?

    Mayo specialists who reviewed recent studies from the NutriRECS consortium recommend, based on the totality of trial evidence, continuing to adhere to current dietary guidelines.

  40. Nov. 27, 2019

    Managing pediatric supraventricular tachycardia

    Advances in ablation technology yield a 95% to 98% success rate and a less than 1% incidence of complications for pediatric patients treated for supraventricular tachycardia.

  41. Nov. 27, 2019

    Post-Fontan operation pregnancy outcomes

    A Mayo Clinic analysis suggests Fontan physiology may not be compatible with good placental health.

  42. Nov. 27, 2019

    Heart Brain Clinic targets cryptogenic stroke

    The Mayo Clinic Heart Brain Clinic is a leading collaborative specialty care model for managing and preventing cryptogenic strokes.

  43. Sept. 27, 2019

    Use of sirolimus associated with a reduction in mortality risk after late post-heart transplantation

    Researchers report a reduced incidence of overall de novo malignancies (excluding nonmelanoma skin cancers) and post-transplantation lymphoproliferative disorders in recipients of heart transplantation who were converte[...]

  44. Sept. 01, 2019

    Dog ownership and cardiovascular health: Results from the Kardiovise 2030 Project

    Project results indicate that, except for smoking, dog owners were more likely to achieve the recommended level of behavioral cardiovascular health metrics (physical activity and diet) than non-dog owners.

  45. Aug. 03, 2019

    Cone reconstruction for Ebstein anomaly

    Mayo Clinic heart surgeons pioneered the cone reconstruction technique to correct Ebstein anomaly. Outcome data shows the technique is safe, durable and effective.

  46. Aug. 03, 2019

    Pulmonary valve replacement the optimal treatment for asymptomatic patient with repaired tetralogy of Fallot

    Mayo Clinic cardiologists determined pulmonary valve replacement was the appropriate treatment for a 32-year-old, asymptomatic patient with a history of tetralogy of Fallot and severe pulmonary regurgitation.

  47. June 01, 2019

    Developing augmented and virtual reality treatments

    Mayo Clinic is rapidly developing augmented and virtual reality ― artificial intelligence technologies ― to improve heart visualizations and create biopatches for arrhythmia therapy.

  48. June 01, 2019

    Coronary anomaly clinic at Mayo Clinic

    A specialized subclinic of clinical cardiologists, cardiac imaging specialists and cardiovascular surgeons is devoted to the care and understanding of anomalies of the coronary arteries.

  49. June 01, 2019

    Myocarditis biomarker predicts severity

    A research collaboration led by Mayo Clinic investigators identified the first biomarker for myocarditis, sera soluble ST2, and found it significantly elevated in men ≤ 50 years, compared with healthy controls and wo[...]

  50. June 01, 2019

    Concomitant mitral valve intervention may increase risk for patients with hypertrophic cardiomyopathy undergoing septal myectomy

    A retrospective study supports the need for increasing surgical experience with septal myectomy for obstructive hypertrophic cardiomyopathy to further improve outcomes.

  51. June 01, 2019

    Artificial intelligence-enabled ECG screening for asymptomatic left ventricular dysfunction

    Mayo researchers use convolutional neural networks to analyze electrocardiograms for silent subclinical, metabolic or structural abnormalities that may predict the presence of asymptomatic left ventricular dysfunction.

  52. June 01, 2019

    Broadening the perspective for regeneration in the heart

    Mayo Clinic's cardiopoietic stem cell experience has created a team with unique expertise in product development, manufacturing, quality assurance and FDA-regulated clinical trial execution that advances regenerative me[...]

  53. April 15, 2019

    Culturally relevant health app shows positive impact

    Fifty African American adults participated in a 10-week study that included podcasts and multimedia educational modules delivered via app. Results show several objectively measured positive outcomes for cardiovascular h[...]

  54. March 29, 2019

    New ATTR amyloidosis treatment

    Amyloidosis is a disease of protein misfolding once considered rare, and increasingly implicated in heart failure. One form affecting the heart is transthyretin (ATTR) amyloidosis, for which treatment options are rapidl[...]

  55. March 29, 2019

    Smart textiles embed monitoring

    Expertise in artificial intelligence-enabled health care powers Mayo Clinic algorithms for heart monitoring and arrhythmia detection that are embedded into textiles to improve care through wearable technology.

  56. Feb. 13, 2019

    New tool predicts myocarditis-related heart failure in men

    Researchers found elevated levels of a protein in the blood, soluble ST2, to be a predictor of heart failure in men under 50 with myocarditis.

  57. Feb. 01, 2019

    Artificial intelligence and contractile dysfunction

    At Mayo Clinic, interdisciplinary teams within Cardiovascular Medicine apply artificial intelligence (AI) techniques to develop a new screening tool for asymptomatic left ventricle dysfunction.

  58. Feb. 01, 2019

    3D printing: The next dimension in cardiac imaging

    Mayo specialists use 3D printing to plan, explain and manage treatment for patients with congenital heart disease and teach complex cardiac anatomy effectively.

  59. Feb. 01, 2019

    Congenital heart disease: The first 50 years … the next 50 years

    Congenital heart disease interventions are evolving due to the adult congenital heart disease subspecialty, improvement in transcatheter valve prostheses and imaging techniques, demand for cardiac replacement, and stem [...]

  60. Dec. 12, 2018

    High-sensitivity troponin assay promises novel uses in managing patients with chronic heart disease

    FDA-approved assays T Gen 5 and hsTnI detect even the smallest rise in troponin levels, allowing for faster recognition of acute myocardial infarction and heart attack.

  61. Dec. 05, 2018

    Innovative management strategy for a fetus with hypoplastic left heart syndrome and intact atrial septum

    Mayo pediatric cardiologists have used an ex utero intrapartum treatment (EXIT) procedure without cardiopulmonary bypass for an open-heart operation. The novel, sequential approach provides a promising strategy for mana[...]

  62. Nov. 08, 2018

    Animal model suggests metabolic syndrome may impair repair

    Research indicates that mesenchymal stem cells in pigs with metabolic syndrome are shifted down a pathway that leads to stasis instead of repair.

  63. Sept. 06, 2018

    Multidisciplinary care and smooth transitions for children with congenital heart disease

    State-of-the-art echocardiography and expertise in complex cardiac conditions help Mayo specialists diagnose and treat patients with congenital heart disease. For patients who need heart transplantation, a Mayo protocol[...]

  64. Aug. 22, 2018

    Mayo Clinic launches Cardiac Sarcoidosis Clinic

    Specialists at Mayo Clinic's Cardiac Sarcoidosis (CS) Clinic collaborate to provide innovative approaches to the diagnosis and management of patients with suspected or clinically definite cardiac sarcoidosis. Resea[...]

  65. Aug. 22, 2018

    CABANA trial results announced at Heart Rhythm Society scientific sessions: The neutral trial that wasn't neutral

    The CABANA trial demonstrated that ablation is an acceptable treatment strategy with low procedural risks even in treating atrial fibrillation (AF) in patients with higher underlying risk.

  66. May 04, 2018

    Stroke reduction in nonvalvular atrial fibrillation with the left atrial appendage closure device: an update

    Left atrial occlusion devices provide a treatment option for patients at significant risk of thromboembolic stroke for whom long-term anticoagulation is either contraindicated or felt to be suboptimal.

  67. Feb. 05, 2018

    Getting to the heart of sleep

    Explore the interplay between sleep, sleep cycle and the heart's recharging system. Obstructive sleep apnea is a strong predictor of sudden cardiac death. The key measure may be blood oxygen levels during episodes.

  68. Jan. 25, 2018

    Using Statin Choice Decision-Aid tool and laboratory testing to reduce cardiac risk

    The Mayo Clinic Statin Choice Decision-Aid tool helps clinicians have meaningful conversations with their patients about whether they should use statins to reduce their risk of cardiovascular disease.

  69. Jan. 23, 2018

    Pediatric cardiogenic shock: What is the role of medical and mechanical circulatory support?

    Pediatric cardiogenic shock is a nonspecific and challenging clinical scenario of decompensated heart failure and impending cardiovascular collapse. Prompt identification, evaluation and treatment of cardiogenic shock c[...]

  70. Jan. 20, 2018

    Ceramides: A class of lipids with links to heart disease

    The pathophysiology of atherosclerosis is a complex intersection of dyslipidemia, inflammation, endothelial dysfunction and platelet activation. Recent data supports causal associations between each of these pathways an[...]

  71. Oct. 03, 2017

    Pectus excavatum: Not just a cosmetic concern

    Untreated pectus excavatum has cosmetic as well as progressive cardiopulmonary consequences. Both open and minimally invasive operative correction by experienced surgeons in high-volume centers yield excellent results.

  72. Sept. 26, 2017

    Life after Fontan palliation

    Mayo Clinic is currently enrolling patients who underwent Fontan procedures in the Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study — the first study exploring alternative therapy for liver di[...]

  73. Aug. 01, 2017

    Transplanted scientist develops new transplant tool

    Ivan Z. Nenandic, Ph.D., discusses attenuation-measuring ultrasound shearwave elastography (AMUSE), a technique that independently measures shearwave velocity and attenuation in tissue, and its application for patients [...]

  74. April 10, 2017

    Do frail individuals benefit from heart surgery?

    Researchers comparing health, well-being, and quality of life between frail and nonfrail patients with aortic valve stenosis before and after valve replacement surgery found that individuals deemed frail before surgery [...]

  75. March 24, 2017

    From apprentice to independent researcher

    Mayo researchers are working with nanoparticles and nanofibers to develop next-generation magnetic grafts for blood vessels and heart valves that will free patients from the need for anticoagulation medication and impro[...]

  76. March 01, 2017

    Renaissance in medicine

    Regenerative medicine delivers specific cells or cell products to diseased tissues or organs to restore function (regeneration); uses healthy cells, tissues or organs to replace damaged ones (replacement); and boosts th[...]

  77. Dec. 05, 2016

    Mayo discovery finalist for science breakthrough

    Researchers genetically engineered mice to kill senescent cells in response to a particular drug. Mice that ate a fat-rich diet and were dosed with the drug carried 60 percent less plaque in major arteries.

  78. Sept. 29, 2016

    Team approach to valve-in-valve therapy: Innovations in treatment of bioprosthetic systemic AV valve dysfunction

    Mayo's structural heart team provides comprehensive care to patients who have previously undergone surgery to replace the mitral or tricuspid valve with a tissue bioprosthesis. Existing dysfunctional bioprosthetic valve[...]

  79. Sept. 26, 2016

    Beat still my beating heart

    Researchers with the Van Cleve Cardiac Regenerative Medicine Program initiative to increase the number of available hearts for transplantation are experimenting to see if a dead heart can be awoken and damage of death m[...]

  80. May 24, 2016

    Marfan syndrome and related disorders

    Effective treatment has resulted in longer lives for patients with Marfan syndrome. Their care involves lifelong monitoring of cardiovascular health and management of noncardiovascular problems.

  81. May 24, 2016

    The Heart Brain Clinic: Optimal team-based coordinated care

    The Heart Brain Clinic provides multidisciplinary evaluations to patients with neurological symptoms that may be attributable to a cardiac etiology such as patent foramen ovale or atrial fibrillation.

  82. April 01, 2016

    Coronary artery calcium score: Are we doing too many or too few?

    Mayo clinicians who specialize in cardiovascular disease prevention believe that a coronary artery calcium score (CACS) can add valuable clinical information in selected patients.

  83. April 01, 2016

    Spontaneous coronary artery dissection: Hidden in plain sight

    The presentation of spontaneous coronary artery dissection (SCAD) mimics other acute coronary events. At Mayo Clinic, patients with SCAD undergo comprehensive vascular imaging; 66 percent of this population has evidence[...]

  84. Jan. 28, 2016

    Pediatric ventricular arrhythmia in a normal heart

    When a child presents with ventricular arrhythmia, specific causes warrant consideration and guide the subsequent work-up and treatment strategy.

  85. Nov. 20, 2015

    Prosthetic valve thrombosis: Time is critical

    Anticoagulant therapy with warfarin with a goal INR of 2 to 3 is effective in treating tissue valve thrombosis in most patients. Cardiac valve replacement and the risk of thrombosis are increasingly common in aging popu[...]

  86. Nov. 20, 2015

    Advancing single ventricle imaging for application of regenerative techniques in congenital heart disease

    Mayo specialists are developing better imaging strategies that can be used to quantify and predict ventricular dysfunction in patients with a single ventricle earlier in the disease course.

  87. Nov. 20, 2015

    PCSK9 inhibition: A game changer in cholesterol management

    PCSK9 inhibitors fill a therapeutic niche for patients with familial hypercholesterolemia or patients with statin intolerance who are not able to achieve the desired LDL-C level with conventional treatments.

  88. May 20, 2015

    Heart failure with preserved ejection fraction (HFpEF): More than diastolic dysfunction

    Mayo Clinic studies test acute inhaled sodium nitrite compared with placebo in people who have heart failure with preserved ejection fraction (HFpEF) and rate adaptive atrial pacing in people with HFpEF and chronotropic[...]

  89. Jan. 27, 2015

    Mayo Clinic announces Carcinoid Heart Disease Clinic

    Carcinoid heart disease affects more than half of patients with carcinoid tumors. A new multidisciplinary clinic provides individualized review of patients to determine the degree of cardiac valve involvement and the be[...]

  90. Jan. 27, 2015

    Arm ergometer provides alternative to conventional stress testing

    Arm ergometer exercise testing can be performed with the patient standing or seated and with or without oxygen consumption measurement. It is helpful for patients with paraplegia or symptoms that occur only during arm w[...]

  91. Nov. 21, 2014

    Leadless pacing available for selected patients

    The Nanostim leadless pacemaker and the Micra transcatheter pacing system are implanted directly into the right ventricular apex.

  92. Nov. 21, 2014

    Percutaneous therapy offers new option for treatment of mitral regurgitation

    Patient experience with the MitraClip device, which fixes the anterior and posterior mitral leaflets together under transesophageal echocardiographic (TEE) guidance to treat mitral regurgitation, has been favorable, wit[...]

  93. Nov. 21, 2014

    Implantable loop recorders in patients with cryptogenic stroke

    Implantable cardiac monitoring with a subcutaneous loop recorder can detect asymptomatic, subclinical atrial fibrillation in 10 percent of patients with cryptogenic stroke at one year, but the subset of patients who wou[...]

  94. Oct. 23, 2014

    Endovascular repair of complex aortic aneurysms

    Fenestrated and branched stent-grafts may provide a safe, effective technique for endovascular repair of aneurysms involving the visceral arteries. Studies indicate a high technical success and a low risk of complicatio[...]

  95. June 18, 2014

    Pregnancy complicated by maternal congenital cardiac disease

    Declining cases of rheumatic heart disease and improved survival of patients with congenital heart disease have resulted in congenital defects being the most common cause of maternal heart disease affecting pregnancy in[...]

  96. June 18, 2014

    Arrhythmias in adult congenital heart disease

    Atrial and ventricular arrhythmias are a major cause of late morbidity and mortality in patients with congenital heart disease, whose care typically requires multimodality strategies involving anti-arrhythmic drugs, det[...]

  97. April 16, 2014

    Role of cardiac MRI in the assessment of cardiac amyloidosis

    Role of cardiac MRI in the assessment of cardiac amyloidosis — Although biopsy is still the gold standard of diagnosis for patients with suspected cardiac amyloidosis, noninvasive cardiac MRI offers superior abili[...]

  98. April 16, 2014

    Investigators identify mortality risk factors in apical hypertrophic cardiomyopathy

    Investigators identify mortality risk factors in apical hypertrophic cardiomyopathy — Kaplan-Meier analysis of 2,662 patients with hypertrophic cardiomyopathy evaluated at Mayo Clinic indicates that predictors of [...]

  99. Sept. 05, 2013

    New protocols allow for MRI in selected patients with pacemakers

    EFFORTLESS registry supports S-ICD efficacy and optimal lead configuration - Studies confirm the first subcutaneous implantable cardioverter-defibrillator system approved for use in the U.S. is as effective as standard [...]